Nurix Therapeutics
NRIX
NRIX
125 hedge funds and large institutions have $1.17B invested in Nurix Therapeutics in 2021 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 43 increasing their positions, 36 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1.76% more ownership
Funds ownership: 88.86% → 90.62% (+1.8%)
1% less capital invested
Capital invested by funds: $1.18B → $1.17B (-$14M)
44% less funds holding in top 10
Funds holding in top 10: 9 → 5 (-4)
Holders
125
Holding in Top 10
5
Calls
$371K
Puts
$2K
Top Buyers
| 1 | +$19.4M | |
| 2 | +$13.9M | |
| 3 | +$13.2M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$13M |
| 5 |
Millennium Management
New York
|
+$10.4M |
Top Sellers
| 1 | -$23.7M | |
| 2 | -$13.5M | |
| 3 | -$11.4M | |
| 4 |
ROTUOC
Regents of the University of California
Oakland,
California
|
-$10.6M |
| 5 |
PM
Ponoi Management
San Francisco,
California
|
-$6.79M |